 |
|
|
|
|
|
|
|
|
|
|
|
Genetic Discrimination Session |
|
| |
|
| |
Intro |
|
|
| |
Webcast
Transcript
|
|
| |
|
| |
Update on the Status of the Genetic Information Nondiscrimination Act of 2005 (S. 306/H.R. 1227) |
|
|
| |
Frank Swain, J.D.
Coalition for Genetic Fairness |
|
|
| |
Webcast
Transcript
|
|
| |
|
| |
Public Attitudes toward Advances in Genetics, Genetic Privacy and the Potential Misuse of Genetic Information |
|
|
| |
Ms. Christy White
Cogent Research |
|
|
| |
Slides
Webcast
Transcript
|
|
| |
|
| |
Q&A and Committee Discussion |
|
|
| |
Webcast
Transcript
|
|
| |
|
|
|
Pharmacogenomics Session |
|
| |
|
| |
Update from the SACGHS Task Force on Pharmacogenomics |
|
|
| |
Emily S. Winn-Deen, Ph.D.
SACGHS Task Force Chair |
|
|
| |
Slides
Webcast
Transcript
|
|
| |
|
| |
Update from FDA |
|
|
| |
Steven I. Gutman, M.D., M.B.A.
Director, Office of In Vitro Diagnostics
U.S. Food and Drug Administration |
|
|
| |
Webcast
Transcript
|
|
| |
|
| |
Allen Rudman, Ph.D.
Associate Director, Office of Clinical Pharmacology and
Biopharmaceutics
Center for Drug Evaluation and Research, FDA |
|
|
| |
Slides
Webcast
Transcript
|
|
| |
|
| |
Q&A and Committee Discussion |
|
|
| |
Facilitator: Dr. Winn-Deen |
|
|
| |
Webcast
Transcript
|
|
| |
|
| |
Public Comments |
|
|
| |
Webcast
Transcript
|
|
| |
|
| |
Feasibility of Integrating Pharmacogenomics into Drug Development from an Economic Perspective |
|
|
| |
Thomas A. Metcalfe
Head of Biomarker Program
F. Hoffmann-La Roche Ltd |
|
|
| |
Slides
Webcast
Transcript
|
|
| |
|
| |
Economic Challenges of Integrating Pharmacogenomics into Clinical Practice |
|
|
| |
Kathryn Phillips, Ph.D.
Professor of Health Economics and Health Services Research
Director, Program in Pharmacogenomics and Population Screening
University of California, San Francisco |
|
|
| |
Slides
Webcast
Transcript
|
|
| |
|
| |
Q&A and Committee Discussion |
|
|
| |
Facilitator: Dr. Winn-Deen |
|
|
| |
Webcast
Transcript
|
|
| |
|
| |
Ethical and Social Issues Associated with Using Race and Genetics in the Study of Differential Drug Response |
|
|
| |
Wylie Burke, M.D., Ph.D.
Professor and Chair, Department of Medical History and Ethics
University of Washington |
|
|
| |
Slides
Webcast
Transcript
|
|
| |
|
| |
Q&A and Committee Discussion |
|
|
| |
Facilitator: Dr. Winn-Deen |
|
|
| |
Webcast
Transcript
|
|
| |
|
| |
Discussion of Next Steps, Work Plan, and Final Work Product for Pharmacogenomics |
|
|
| |
Facilitators: Dr. Winn-Deen and Ms. Berry |
|
|
| |
Webcast
Transcript
|
|
| |
|
|
|
Planning for March 2006 SACGHS Meeting and Concluding Remarks |
|
|
| |
Ms. Berry |
|
|
| |
Webcast
Transcript
|
|
| |
|
|
|
ADJOURN |
|
| |
|
Top of Page |
